Skip to main content
Publications
Lapuerta P, Joish V, Ervin C, Evans E, Reaney M, Preblick R, De Fanti B, Castro R, DiBenedetti D. Patients with type 1 diabetes value increased glucose stability and associate it with improved well-being: exit interviews from Sotagliflozin Phase 3 study. Poster presented at the 2018 European Association for the Study of Diabetes (EASD) Conference; October 2, 2018. Berlin, Germany.
Blonde L, Raccah D, Lew E, Meyers J, Nikonova E, Ajmera M, Davis KL, Bertolini M, Guerci B. Treatment intensification in type 2 diabetes: a real world study of 2-OAD regimens, GLP-1 RAx, or basal insulin. Diabetes Ther. 2018 Jun;9(3):1169-84. doi: 10.1007/s13300-018-0429-x
Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, Lee E, Campbell M, Basarir H, White D, REPOSE group. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial. BMJ Open. 2018 Apr 7;8(4):e016766. doi: 10.1136/bmjopen-2017-016766